Cameron Health's entirely subcutaneous implantable cardioverter-defibrillator (ICD) – said to be the first of its kind – can detect and treat ventricular fibrillation, two trials have shown. The lead UK investigator of the two company-sponsored trials, Dr Andrew Grace, of the ...
Please Login to read the full article.
